Non-Dysplastic Barrett’s Esophagus

Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher

Friendswood, Texas, U.S., September 28, 2026 Castle Biosciences has announced new clinical evidence demonstrating how its TissueCypher® Barrett’s Esophagus...

By cGxPwire Editor
September 30, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Non-Dysplastic Barrett’s Esophagus

Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher